Scale The Latitude Of Generic Drugs With Formulation Development Service LATITUDE Pharmaceuticals Inc.


Posted December 21, 2018 by timothyhtraub

LATITUDE Pharmaceuticals Inc. is a leading Formulation Development Service that particularly specializes in formulation of the most insoluble, highly unstable compounds or compounds with poor bioavailability earning

 
SAN DIEGO, CA (DECEMBER 21, 2018)- Drugs and pharmaceutical industry is always in a constant lookout for innovations in the drugs and their delivery systems. The industry thrives on new formulations and solutions that implement medical care with utmost satisfaction. This is being accomplished by formulation development service, LATITUDE Pharmaceuticals Inc. LATITUDE Pharmaceuticals Inc. is consistently providing the innovative NCE and generic drug formulation development services along with developing proprietary drug delivery systems for the human and veterinary pharmaceutical industries. With the focus primarily on developing formulations for compounds that are highly insoluble, highly unstable, and/or have poor bioavailability, LATITUDE Pharmaceuticals Inc. has carved an unparalleled niche for itself in the industry.

LATITUDE Pharmaceuticals Inc. specializes in developing their own formulations for the existing drugs in order to enhance their usability. The team of scientists at LATITUDE Pharmaceuticals Inc. is able to achieve extraordinary results owing to the use of multiple instruments and techniques. "Our experienced and well-trained scientists capably develop and perform a wide range of qualitative and quantitative methods required in drug formulation development and drug stability evaluation." The analytical instrumentation that are being used in the laboratories of LATITUDE Pharmaceuticals Inc. include Franz cell apparatus for Franz cell apparatus testing, Halogen moisture analyzer, Helium pycnometer, HPLCs with UV, PDA, ELSD, RI, fluorescence and mass detectors, Inhalation particle analyzer (Next Generation Impactor, NGI), Injection force analyzer, Karl Fischer titrator, Label and barcode printers, LCMS/LCQ, Light scattering detector, Moisture sorption isotherm analyzer, Osmometers and Particle analyzers (Mastersizer with dry & wet samplers, nano-sizer, HIAC, DLS) among many others.

LATITUDE Pharmaceuticals Inc. is also performing deformulation generic drug product development. "Deformulation, or reverse engineering, is the separation, identification and quantitation of individual components or ingredients in a drug product." Through deformulation, LATITUDE Pharmaceuticals Inc. accumulates essential parameters like the ingredients, their quantities and the physical and chemical properties from the brand name drug (i.e., Reference Listed Drug), which are then incorporated in the FDA approved generic substitute. In addition to this, LATITUDE perform services like patent research, deformulation, and generics formulation development.

This Formulation Development Contract Research Organization is highly responsive and efficient and also customizes the approach in order to accommodate all the specific requirements of the clients while saying within the prescribed deadlines. “Our formulation development services, based on broad drug substance experience, cover the spectrum from preformulation, dosage form development through GLP toxicology (GLP tox) studies, and process development for cGMP manufacturing".

About LATITUDE Pharmaceuticals Inc.:
LATITUDE Pharmaceuticals Inc. is a formulation development service that implements generic drug formulation as well as develops drug delivery systems for both human as well as veterinary pharmaceutical industries.

To read more about LATITUDE Pharmaceuticals Inc. visit http://www.latitudepharma.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By LATITUDE
Phone 858-546-0924
Business Address 9675 Businesspark Avenue
San Diego, CA 92131
Country United States
Categories News
Tags analytical method development , hplc method development , particle size distribution analysis
Last Updated December 21, 2018